SIGLEC9 and Sepsis: In spite of the proven effects of SIGLEC9 and TSPO on sepsis and sepsis-related pathological mechanisms as well as the potent underlying roles of these four genes in immune and inflammatory responses, none of these genes have been studied or explored in se-ARDS at a clinical level.